| LogGENE: A smooth alternative to check loss for Deep Healthcare Inference Tasks | Jun 19, 2022 | Binary ClassificationDrug Design | —Unverified | 0 | 0 |
| Low cost prediction of probability distributions of molecular properties for early virtual screening | Jul 21, 2022 | Drug Design | —Unverified | 0 | 0 |
| Machine learning for the prediction of safe and biologically active organophosphorus molecules | Feb 21, 2023 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Machine Learning Implicit Solvation for Molecular Dynamics | Jun 14, 2021 | BIG-bench Machine LearningDrug Design | —Unverified | 0 | 0 |
| Mathematical deep learning for pose and binding affinity prediction and ranking in D3R Grand Challenges | Apr 27, 2018 | Drug DesignPose Prediction | —Unverified | 0 | 0 |
| Mayer-homology learning prediction of protein-ligand binding affinities | Aug 23, 2024 | DescriptiveDrug Design | —Unverified | 0 | 0 |
| Meta-Path-based Probabilistic Soft Logic for Drug-Target Interaction Prediction | Jun 25, 2023 | Drug Design | —Unverified | 0 | 0 |
| Meta-QSAR: a large-scale application of meta-learning to drug design and discovery | Sep 12, 2017 | BIG-bench Machine LearningDrug Design | —Unverified | 0 | 0 |
| Meta Reinforcement Learning with Latent Variable Gaussian Processes | Mar 20, 2018 | Drug DesignGaussian Processes | —Unverified | 0 | 0 |
| Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning | Apr 29, 2020 | Deep Reinforcement LearningDrug Design | —Unverified | 0 | 0 |
| Molecular Diffusion Models with Virtual Receptors | Jun 26, 2024 | Drug DesignProtein Folding | —Unverified | 0 | 0 |
| Molecular docking studies on Jensenone from eucalyptus essential oil as a potential inhibitor of COVID 19 corona virus infection | Apr 17, 2020 | Drug DesignMolecular Docking | —Unverified | 0 | 0 |
| Molecular Graph Generation via Geometric Scattering | Oct 12, 2021 | Drug DesignGraph Generation | —Unverified | 0 | 0 |
| Molecular Property Prediction by Semantic-invariant Contrastive Learning | Mar 13, 2023 | Contrastive LearningDrug Design | —Unverified | 0 | 0 |
| Molecule Generation for Drug Design: a Graph Learning Perspective | Feb 18, 2022 | Drug DesignGraph Learning | —Unverified | 0 | 0 |
| Molecule Generation from Input-Attributions over Graph Convolutional Networks | Jan 25, 2022 | Drug Design | —Unverified | 0 | 0 |
| Antibody DomainBed: Out-of-Distribution Generalization in Therapeutic Protein Design | Jul 15, 2024 | Domain GeneralizationDrug Design | —Unverified | 0 | 0 |
| Navigating the Maize: Cyclic and conditional computational graphs for molecular simulation | Jan 22, 2024 | Active LearningComputational chemistry | —Unverified | 0 | 0 |
| New Candidates for Furin Inhibition as Probable Treat for COVID-19: Docking Output | Jul 27, 2021 | Drug Design | —Unverified | 0 | 0 |
| NLRP3 monomer Functional Dynamics: from the Effects of Allosteric Binding to Implications for Drug Design | Sep 7, 2023 | Drug Design | —Unverified | 0 | 0 |
| Old Drugs for Newly Emerging Viral Disease, COVID-19: Bioinformatic Prospective | Mar 10, 2020 | Drug Design | —Unverified | 0 | 0 |
| One-way Explainability Isn't The Message | May 5, 2022 | Drug Design | —Unverified | 0 | 0 |
| Optimization of Tree Ensembles | May 30, 2017 | Drug Design | —Unverified | 0 | 0 |
| Optimized Drug Design using Multi-Objective Evolutionary Algorithms with SELFIES | May 1, 2024 | Drug DesignEvolutionary Algorithms | —Unverified | 0 | 0 |
| Optimizing Drug Design by Merging Generative AI With Active Learning Frameworks | May 4, 2023 | Active LearningDrug Design | —Unverified | 0 | 0 |
| Overview of Current Type I/II Kinase Inhibitors | Nov 23, 2018 | Drug DesignVocal Bursts Type Prediction | —Unverified | 0 | 0 |
| ParaVS: A Simple, Fast, Efficient and Flexible Graph Neural Network Framework for Structure-Based Virtual Screening | Feb 8, 2021 | Drug DesignGraph Neural Network | —Unverified | 0 | 0 |
| PepINVENT: Generative peptide design beyond the natural amino acids | Sep 21, 2024 | Drug Design | —Unverified | 0 | 0 |
| Persistent Dirac for molecular representation | Feb 5, 2023 | Drug Designmolecular representation | —Unverified | 0 | 0 |
| Persistent spectral based machine learning (PerSpect ML) for drug design | Feb 3, 2020 | BIG-bench Machine LearningDrug Design | —Unverified | 0 | 0 |
| Pharmacophore-Conditioned Diffusion Model for Ligand-Based De Novo Drug Design | May 15, 2025 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Pharmacophore-guided de novo drug design with diffusion bridge | Dec 10, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Pharmacoprint -- a combination of pharmacophore fingerprint and artificial intelligence as a tool for computer-aided drug design | Oct 4, 2021 | Dimensionality ReductionDrug Design | —Unverified | 0 | 0 |
| Phen-DC 3 Induces Refolding of Human Telomeric DNA into a Chair-Type Antiparallel G-Quadruplex through Ligand Intercalation | Jun 7, 2023 | Drug Design | —Unverified | 0 | 0 |
| PILOT: Equivariant diffusion for pocket conditioned de novo ligand generation with multi-objective guidance via importance sampling | May 23, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| PlayMolecule Viewer: a toolkit for the visualization of molecules and other data | Dec 22, 2023 | Data VisualizationDrug Design | —Unverified | 0 | 0 |
| PointGAT: A quantum chemical property prediction model integrating graph attention and 3D geometry | Oct 8, 2023 | 3D geometryComputational chemistry | —Unverified | 0 | 0 |
| Position: Graph Learning Will Lose Relevance Due To Poor Benchmarks | Feb 20, 2025 | BenchmarkingCombinatorial Optimization | —Unverified | 0 | 0 |
| Predicting drug-target interaction using 3D structure-embedded graph representations from graph neural networks | Apr 17, 2019 | Drug DesignGraph Attention | —Unverified | 0 | 0 |
| Prediction of protein allosteric signalling pathways and functional residues through paths of optimised propensity | Jul 14, 2022 | Drug Design | —Unverified | 0 | 0 |